ProAxsis specialises in the development and commercialisation of in vitro diagnostic laboratory assays and point–of–care tests designed to measure active protease biomarkers of disease.
GLT’s primary function is to carry out innovative, industry–led research and development to provide green and sustainable solutions to industrial problems.